Table 2

Emergence of imipenem resistance during treatment of Pseudomonas pneumonia

Authors (year) [ref.]
Daily dose (g)
Treatment-emergent resistance (n/total [%])

Salata et al. (1985) [36]
1.5 to 3
6/10 (60)
Quinn et al. (1986) [38]


Norrby et al. (1993) [35]
2
6/19 (32)
Cometta et al. (1994) [32]
2a
14/21 (67)
Fink et al. (1994) [33]
3
17/32 (53)
Jaccard et al. (1998) [34]
2
6/24 (25)
Zanetti et al. (2003) [37]
2
9/27 (33)

aSome patients also received 150 mg netilmicin twice a day.

Rahal Critical Care 2008 12(Suppl 4):S5   doi:10.1186/cc6821